Hiroaki Mitsuya
Hiroaki Mitsuya (満屋 裕明, Mitsuya Hiroaki, born 1950) is a Japanese virologist famous for his role in discovery of the anti-HIV drug zidovudine (AZT) as well as other anti-AIDS drugs including didanosine (ddI) and zalcitabine (ddC).
Mitsuya was born in Sasebo, Nagasaki and received his M.D. and Ph.D. from Kumamoto University. He joined the American National Cancer Institute in Bethesda, Maryland, in 1982, working initially on Human T-lymphotropic virus 1 before switching his attention to HIV. His identification of AZT as an anti-HIV drug, as well as the anti-HIV properties of didanosine and zalcitabine, was made in 1985. He was appointed Professor of Hematology, Rheumatology and Clinical Immunology at Kumamoto University Graduate School of Medical And Pharmaceutical Sciences.
In December, 2006, he was awarded the first NIH World AIDS Day Award for his work in developing drugs for AIDS. Mitsuya has been chief of the NCI's Experimental Retrovirology Section since 1991.
References and Links
- Page describing Dr. Mitsuya's research on NCI website
- Yarchoan R, Mitsuya H, Broder S. AIDS therapies. Scientific American 1988;259(4):110-9
- Articles with short description
- Short description matches Wikidata
- Articles containing Japanese-language text
- Articles with FAST identifiers
- Articles with ISNI identifiers
- Articles with VIAF identifiers
- Articles with GND identifiers
- Articles with LCCN identifiers
- Articles with NDL identifiers
- Articles with NKC identifiers
- Articles with CINII identifiers
- Articles with ORCID identifiers
- 1950 births
- Living people
- Japanese virologists
- HIV/AIDS researchers
- People from Sasebo
- Kumamoto University alumni
- Academic staff of Kumamoto University
- All stub articles
- Japanese scientist stubs